other material
confidence high
sentiment neutral
materiality 0.50
Cartesian Therapeutics Series A Preferred automatically converts, resulting in 17.8M shares outstanding
Cartesian Therapeutics, Inc.
- Automatic conversion of Series A Non-Voting Convertible Preferred Stock occurred on April 8, 2024.
- After conversion, common stock outstanding totals 17,779,787 shares.
- No further Series A Preferred shares remain outstanding; previously approved by stockholders on March 27, 2024.
- Company also filed updated corporate slide presentation for investor conferences.